For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220503:nRSC0874Ka&default-theme=true
RNS Number : 0874K Puma VCT 13 PLC 03 May 2022
Puma VCT 13 plc (the "Company")
3 May 2022
Disposal of stake in Tictrac Limited
The Board of Puma VCT 13 plc is pleased to announce that Tictrac Limited
("Tictrac") has been acquired by Dialogue Health Technologies Inc. In 2020 the
Company invested £1,850,000 in Tictrac. The exit represents a 1.93x return on
the Company's investment, representing an IRR of 37.18%. The resulting cash
proceeds attributable to the Company are not materially different from the
value at which the Company currently holds its investment in Tictrac.
Tictrac offers an advanced health and wellness app for insurance companies and
corporate clients to provide to their user bases. The app integrates data from
wearable technology, delivering it to end users in a digestible format to
drive up levels of engagement and increase customer loyalty.
For further information please contact:
Graham Shore
Puma VCT 13 plc
020 7408 4050
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DISUOOWRUKUVRRR